Free Trial

Theravance Biopharma (TBPH) Insider Trading & Ownership

Theravance Biopharma logo
$9.59 -0.14 (-1.44%)
(As of 12/20/2024 05:16 PM ET)

Theravance Biopharma (NASDAQ:TBPH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.90%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$7.80 M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$82,922.34
Get TBPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Theravance Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TBPH Insider Buying and Selling by Quarter

Theravance Biopharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/11/2024Rhonda FarnumSVPSell4,000$9.00$36,000.00  
8/7/2024Eli SamahaMajor ShareholderBuy999,800$7.80$7,798,440.00  
7/10/2024Rhonda FarnumSVPSell4,000$9.00$36,000.00  
2/22/2024Rhonda FarnumSVPSell1,254$8.71$10,922.34  
(Data available from 1/1/2013 forward)

TBPH Insider Trading Activity - Frequently Asked Questions

The list of insiders at Theravance Biopharma includes Eli Samaha, Rhonda Farnum, Richard A Graham, and Rick E Winningham. Learn more on insiders at TBPH.

6.90% of Theravance Biopharma stock is owned by insiders. Learn more on TBPH's insider holdings.

The following insider purchased TBPH shares in the last 24 months: Eli Samaha ($7,798,440.00).

Insiders have purchased a total of 999,800 TBPH shares in the last 24 months for a total of $7,798,440.00 bought.

The following insiders have sold TBPH shares in the last 24 months: Rhonda Farnum ($174,936.95), and Richard A Graham ($244,255.39).

Insiders have sold a total of 41,932 Theravance Biopharma shares in the last 24 months for a total of $419,192.34 sold.

Theravance Biopharma Key Executives

  • Rick E. Winningham
    Chairman & Chief Executive Officer
  • Andrew Asa Hindman
    Chief Financial Officer & Senior Vice President
  • Vijay Sabesan
    Senior Vice President-Technical Operations
  • Philip D. Worboys
    Senior VP-Research & Translational Science
  • Bradford J. Shafer
    Secretary, Executive VP & General Counsel


This page (NASDAQ:TBPH) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners